Ces Device for Anxiety

What are the indications of ces device for anxiety?

 

• Feelings of insignificance
• Diminished enthusiasm for activities and hobbies
• Restlessness or apprehension Persistent and unfounded worries
• Experiencing either excessive sleep or insomnia
• Enhancing cognitive focus

 

 

What's the technical parameter of the COZING-IN02?

1. Configure frequency settings ranging from 1 to 999Hz.

2. Locking Mechanism: Safeguard device settings to prevent unintended adjustments.

3. Touch-Sensitive Screen: Intuitive and user-friendly interface for effortless operation.

4. Adjustable Strength: Choose from 10 levels of intensity for personalized therapy.

5. Timer Selection: Select from a range of 10 timer options for convenience.

6. Dual Therapy Capability: Simultaneously or independently utilize acupuncture and insomnia treatment functions.

7. USB-C Charging Port: Convenient charging port for versatile power supply.

8. Personalization: Accommodates customized requirements (wavelength, intensity, color, packaging) starting from 100 units, with support for OEM and ODM services.

The regulation of our moods and emotions, such as anxiety, is orchestrated by electrochemical signals within the brain. Studies have revealed that the electrical patterns in the brain govern the release of neurochemicals responsible for managing our moods, emotions, sleep, and cognitive functions. When stress disrupts this electrical activity, it leads to an imbalance in the hormones and neurotransmitters that govern our emotional state. Through indirect stimulation of brain tissue in the hypothalamic region, CES (Cranial Electrotherapy Stimulation) devices utilize low-frequency electrical pulses to induce relaxation by transmitting signals to the brain.

Research and meta-analyses indicate that cranial electrostimulation (CES) stands as a secure and efficient remedy for generalized anxiety. An analysis pooling data from double-blind controlled trials contrasting CES against sham treatment (where electrodes are applied without current) revealed notable enhancements in measures of generalized anxiety across 7 out of 8 studies. Notably, statistical significance in the magnitude of improvement was attained in 4 of these trials.

• A comprehensive review encompassing 34 sham-controlled trials spanning from 1963 to 1996 affirmed that regular CES interventions yield short-term relief from symptoms of generalized anxiety, primarily mediated by direct modulation of autonomic brain centers.
• A 10-week open trial examining daily self-administered CES therapy among 182 individuals diagnosed with DSM-III anxiety disorders unveiled significant anxiety reduction reported by 73% of patients, with sustained benefits observed at a 6-month follow-up. Remarkably, a quarter of participants in this trial had previously failed conventional drug therapies, while 58% had no prior exposure to any form of anxiety treatment.
• Generally, patients undergoing 4 to 6 CES treatments tend to experience more enduring reductions in anxiety compared to those receiving fewer sessions.
• Individuals diagnosed with one or more phobias according to DSM criteria reported noteworthy reductions in transient anxiety subsequent to exposure to the phobic stimulus followed by 30 minutes of CES therapy.
• Comparable levels of anxiety reduction were achieved with CES and traditional anti-anxiety medications, implying that CES may offer a viable alternative for phobic patients seeking to discontinue prescription drugs.
• Hospitalized patients with histories of substance abuse reported significant anxiety alleviation compared to matched counterparts who underwent sham CES interventions.